title: Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor: evidence for the allosteric modulation of the dopamine receptor.
abstract: The present study was undertaken to investigate the mechanistic role of l-prolyl-l-leucyl-glycinamide (PLG) in modulating agonist binding to the dopamine D(2L) receptor. Competition and displacement assays indicate that the photoaffinity-labeling peptidomimetics of PLG, 3(R)-[(4(S)-(4-azido-2-hydroxy-benzoyl) amino-2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide hydrochloride (1a) and 3(R)-[(4(S)-(4-azido-2-hydroxy-5-iodo-benzoyl)amino-2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide hydrochloride (1b) bind at the same site as PLG. Autoradiography was used to establish the covalent binding of [(125)I]-1b to an approximately 51kDa protein in bovine striatal membranes. Western blot analysis with a dopamine D(2L)-specific antibody, in combination with autoradiography, following a two-dimensional gel separation, suggested this approximately 51kDa protein to be the dopamine D(2L) receptor. Further evidence for binding of 1b to dopamine D(2L) was provided by samples immunoprecipitated with the D(2L) antibody. These samples were analyzed by western blotting in parallel with autoradiography of [(125)I]-1b labeled protein. Both methods revealed bands at approximately 51kDa. Furthermore, PLG is shown to compete with 1b for binding to the dopamine D(2L) receptor as determined by autoradiography, as well as competition experiments with PLG and 1a. Collectively, these findings suggest the successful development of a photoaffinity-labeling agent, compound 1b, that has been used to elucidate the interaction of PLG specifically with the dopamine D(2L) receptor.
authors.affiliation: Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada.
authors.forename: Amandeep
authors.initials: A
authors.lastname: Mann
authors.forename: Vaneeta
authors.initials: V
authors.lastname: Verma
authors.forename: Dipannita
authors.initials: D
authors.lastname: Basu
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Skoblenick
authors.forename: Michael G R
authors.initials: MG
authors.lastname: Beyaert
authors.forename: Abigail
authors.initials: A
authors.lastname: Fisher
authors.forename: Nancy
authors.initials: N
authors.lastname: Thomas
authors.forename: Rodney L
authors.initials: RL
authors.lastname: Johnson
authors.forename: Ram K
authors.initials: RK
authors.lastname: Mishra
mesh_terms: D000494:Allosteric Regulation; D000818:Animals; D001345:Autoradiography; D001667:Binding, Competitive; D015153:Blotting, Western; D002417:Cattle; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D015180:Electrophoresis, Gel, Two-Dimensional; D047468:Immunoprecipitation; D009075:MSH Release-Inhibiting Hormone / Q000737:chemistry / Q000378:metabolism*; D015394:Molecular Structure; D057786:Peptidomimetics / Q000378:metabolism*; D019920:Photoaffinity Labels / Q000378:metabolism; D017448:Receptors, Dopamine D2 / Q000378:metabolism*
chemical_list: D057786:Peptidomimetics; D019920:Photoaffinity Labels; D017448:Receptors, Dopamine D2; C113776:dopamine D2L receptor; D009075:MSH Release-Inhibiting Hormone; D004298:Dopamine